Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05813600
Status:
COMPLETED
Last Update Posted:
2023-04-14
First Post:
2023-04-07
Brief Title:
Efficacy and Safety of NirmatrelvirRitonavir for Treating Omicron Variant of COVID-19
Sponsor:
Xiangao Jiang
Organization:
Wenzhou Central Hospital
Organization Data
Organization:
Wenzhou Central Hospital
Class:
OTHER
Study ID:
Xiangao Jiang
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xiangao Jiang
Lead Sponsor Class:
OTHER
Responsible Party:
Xiangao Jiang
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Wenzhou Central Hospital
Old Name:
None
Old Organization:
None